Zhende Medical Co Ltd (603301) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Zhende Medical Co Ltd (603301) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.93 Million ≈ $14.92 Million USD) by net assets (CN¥5.99 Billion ≈ $875.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhende Medical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Zhende Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Zhende Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhende Medical Co Ltd (603301) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Zhende Medical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhende Medical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Centrus Energy Corp.
NYSE MKT:LEU
-0.063x
Hafnia Limited
NYSE:HAFN
0.051x
Sai MicroElectronics Inc
SHE:300456
-0.006x
GZ Port
SHG:601228
0.010x
BankUnited Inc
NYSE:BKU
0.002x
Knowles Cor
NYSE:KN
-0.001x
Signet Jewelers Ltd
NYSE:SIG
-0.076x
Assured Guaranty Ltd
NYSE:AGO
0.034x

Annual Cash Flow Conversion Efficiency for Zhende Medical Co Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Zhende Medical Co Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Zhende Medical Co Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.96 Billion
≈ $872.47 Million
CN¥538.49 Million
≈ $78.80 Million
0.090x +15.48%
2024-12-31 CN¥5.90 Billion
≈ $862.83 Million
CN¥461.14 Million
≈ $67.48 Million
0.078x -3.05%
2023-12-31 CN¥5.60 Billion
≈ $820.10 Million
CN¥452.11 Million
≈ $66.16 Million
0.081x -62.73%
2022-12-31 CN¥5.76 Billion
≈ $842.43 Million
CN¥1.25 Billion
≈ $182.34 Million
0.216x +17.52%
2021-12-31 CN¥4.44 Billion
≈ $649.65 Million
CN¥817.63 Million
≈ $119.64 Million
0.184x -73.64%
2020-12-31 CN¥4.47 Billion
≈ $653.65 Million
CN¥3.12 Billion
≈ $456.68 Million
0.699x +394.48%
2019-12-31 CN¥1.40 Billion
≈ $204.82 Million
CN¥197.76 Million
≈ $28.94 Million
0.141x +684.88%
2018-12-31 CN¥1.12 Billion
≈ $164.57 Million
CN¥20.25 Million
≈ $2.96 Million
0.018x -94.47%
2017-12-31 CN¥560.19 Million
≈ $81.97 Million
CN¥182.34 Million
≈ $26.68 Million
0.326x +2.93%
2016-12-31 CN¥438.18 Million
≈ $64.12 Million
CN¥138.57 Million
≈ $20.28 Million
0.316x -41.84%
2015-12-31 CN¥262.45 Million
≈ $38.40 Million
CN¥142.70 Million
≈ $20.88 Million
0.544x -31.23%
2014-12-31 CN¥105.77 Million
≈ $15.48 Million
CN¥83.63 Million
≈ $12.24 Million
0.791x --

About Zhende Medical Co Ltd

SHG:603301 China Medical Instruments & Supplies
Market Cap
$3.37 Billion
CN¥23.04 Billion CNY
Market Cap Rank
#4569 Global
#736 in China
Share Price
CN¥87.33
Change (1 day)
-0.51%
52-Week Range
CN¥22.22 - CN¥100.22
All Time High
CN¥100.22
About

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pa… Read more